BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 29414812)

  • 21. Importance of CD45RO+ tumor-infiltrating lymphocytes in post-operative survival of breast cancer patients.
    Ahmadvand S; Faghih Z; Montazer M; Safaei A; Mokhtari M; Jafari P; Talei AR; Tahmasebi S; Ghaderi A
    Cell Oncol (Dordr); 2019 Jun; 42(3):343-356. PubMed ID: 30825183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathologic and prognostic significance of tumor-infiltrating CD8+ T cells in patients with hepatocellular carcinoma: A meta-analysis.
    Xu X; Tan Y; Qian Y; Xue W; Wang Y; Du J; Jin L; Ding W
    Medicine (Baltimore); 2019 Jan; 98(2):e13923. PubMed ID: 30633166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD3 high and FoxP3 - tumor-infiltrating lymphocytes in the invasive margin as a favorable prognostic marker in patients with invasive urothelial carcinoma of the bladder.
    Sun ZJ; Zhao JW; Zhao M; Chen Y; Zhang X; Li HC; Wu GQ; Zhang DH
    Anticancer Drugs; 2023 Aug; 34(7):844-851. PubMed ID: 36563023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor-infiltrating lymphocytes are significantly associated with better overall survival and disease-free survival in triple-negative but not estrogen receptor-positive breast cancers.
    Krishnamurti U; Wetherilt CS; Yang J; Peng L; Li X
    Hum Pathol; 2017 Jun; 64():7-12. PubMed ID: 28153508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prognostic role of tumor infiltrating T-lymphocytes in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis.
    de Ruiter EJ; Ooft ML; Devriese LA; Willems SM
    Oncoimmunology; 2017; 6(11):e1356148. PubMed ID: 29147608
    [No Abstract]   [Full Text] [Related]  

  • 26. Association between levels of tumor-infiltrating lymphocytes in different subtypes of primary breast tumors and prognostic outcomes: a meta-analysis.
    He L; Wang Y; Wu Q; Song Y; Ma X; Zhang B; Wang H; Huang Y
    BMC Womens Health; 2020 Sep; 20(1):194. PubMed ID: 32891135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumour infiltrating lymphocytes correlate with improved survival in patients with oesophageal adenocarcinoma.
    Noble F; Mellows T; McCormick Matthews LH; Bateman AC; Harris S; Underwood TJ; Byrne JP; Bailey IS; Sharland DM; Kelly JJ; Primrose JN; Sahota SS; Bateman AR; Thomas GJ; Ottensmeier CH
    Cancer Immunol Immunother; 2016 Jun; 65(6):651-62. PubMed ID: 27020682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T-bet
    Mori H; Kubo M; Kai M; Yamada M; Kurata K; Kawaji H; Kaneshiro K; Osako T; Nishimura R; Arima N; Okido M; Kishimoto J; Oda Y; Nakamura M
    Breast Cancer Res Treat; 2019 Aug; 176(3):569-577. PubMed ID: 31069590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic implications of intratumoral CD103+ tumor-infiltrating lymphocytes in pulmonary squamous cell carcinoma.
    Koh J; Kim S; Kim MY; Go H; Jeon YK; Chung DH
    Oncotarget; 2017 Feb; 8(8):13762-13769. PubMed ID: 28099920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study.
    Miyashita M; Sasano H; Tamaki K; Hirakawa H; Takahashi Y; Nakagawa S; Watanabe G; Tada H; Suzuki A; Ohuchi N; Ishida T
    Breast Cancer Res; 2015 Sep; 17(1):124. PubMed ID: 26341640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor-infiltrating lymphocytes in breast cancer predict the response to chemotherapy and survival outcome: A meta-analysis.
    Wang K; Xu J; Zhang T; Xue D
    Oncotarget; 2016 Jul; 7(28):44288-44298. PubMed ID: 27329588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Prognostic Value of Tumor Infiltrating Lymphocytes After Radical Cystectomy for Bladder Cancer: A Systematic Review and Meta-Analysis.
    Kawada T; Yanagisawa T; Rajwa P; Motlagh RS; Mostafaei H; Quhal F; Laukhtina E; Pallauf M; König F; Pradere B; Araki M; Nasu Y; Shariat SF
    Clin Genitourin Cancer; 2024 Apr; 22(2):535-543.e4. PubMed ID: 38336572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prognostic value of T lymphocytes infiltration in breast cancer].
    Yu HM; Jiao SC; Yang JL; Wang JD
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Apr; 35(2):199-206. PubMed ID: 23643010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic Significance of Tumor-Infiltrating Lymphocyte Grade in Melanoma: A Meta-Analysis.
    Sun Q; Sun H; Wu N; Cong L; Cong X
    Dermatology; 2020; 236(6):481-492. PubMed ID: 32023619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic impact of tumor-infiltrating lymphocytes in high grade serous ovarian cancer: a systematic review and meta-analysis.
    Hao J; Yu H; Zhang T; An R; Xue Y
    Ther Adv Med Oncol; 2020; 12():1758835920967241. PubMed ID: 33193829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic impact of the red cell distribution width in esophageal cancer patients: A systematic review and meta-analysis.
    Xu WY; Yang XB; Wang WQ; Bai Y; Long JY; Lin JZ; Xiong JP; Zheng YC; He XD; Zhao HT; Sang XT
    World J Gastroenterol; 2018 May; 24(19):2120-2129. PubMed ID: 29785080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of tumor infiltrating lymphocyte subsets in breast cancer depends on hormone receptor status.
    Chung YR; Kim HJ; Jang MH; Park SY
    Breast Cancer Res Treat; 2017 Feb; 161(3):409-420. PubMed ID: 27913931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic role of tumor-infiltrating lymphocytes in gastric cancer: A systematic review and meta-analysis.
    Lee JS; Won HS; Sun S; Hong JH; Ko YH
    Medicine (Baltimore); 2018 Aug; 97(32):e11769. PubMed ID: 30095632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significance of Tumor-Infiltrating Lymphocytes and the Expression of Topoisomerase IIα in the Prediction of the Clinical Outcome of Patients with Triple-Negative Breast Cancer after Taxane-Anthracycline-Based Neoadjuvant Chemotherapy.
    Rao N; Qiu J; Wu J; Zeng H; Su F; Qiu K; Wu J; Yao H
    Chemotherapy; 2017; 62(4):246-255. PubMed ID: 28472798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Prognostic Significance of the Tumor-infiltrating Programmed Cell Death-1
    Shibutani M; Maeda K; Nagahara H; Fukuoka T; Nakao S; Matsutani S; Hirakawa K; Ohira M
    Anticancer Res; 2017 Aug; 37(8):4165-4172. PubMed ID: 28739701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.